UMB 425 is being called a breakthrough in the development of therapeutics to treat chronic pain, acts on two different opioid receptors with diminished tolerance over time and no obvious toxic effects.
A team of researchers led by Andrew Coop, PhD, professor and chair of the Department of Pharmaceutical Sciences (PSC) at the University of Maryland School of Pharmacy (UMSOP), has developed a new opioid drug that shows great potential to advance treatment and improve quality of life for individuals living with chronic pain. Spotlighted in a recent issue of ACS Chemical Neuroscience, the compound, known as UMB 425, is as strong as morphine, but displays diminished tolerance over time with no obvious toxic effects.
“UMB 425 is a breakthrough in the development of therapeutics to treat chronic pain,” says Coop. “Unlike other drugs developed to act on only one biological target, UMB 425 acts on two different opioid receptors in the body. When activated at the same time, these receptors work together to provide pain relief and slow the body’s development of tolerance to the drug. This diminished tolerance allows a lower dose of the opioid to be administered for a longer time period, while still achieving the same level of pain relief.”
For individuals living with chronic pain, either as a result of injury or disease such as arthritis, opioids are the standard treatment. But as the dosage increases to offset the body’s tolerance to their effects, opioids cause a number of adverse effects, including constipation, nausea, drowsiness, and dizziness. The unique dual-profile of UMB 425 – made possible through Coop’s collaborations with Alexander MacKerell, PhD, professor in PSC and director of the School’s Computer Aided Drug Design Center, and Maureen Kane, PhD, assistant professor in PSC and co-director of the School’s Mass Spectrometry Facility – provides both pain relief as well as diminished tolerance in one drug.
“Historically, medicinal chemists have developed drugs aimed at only one biological target,” says Coop. “However, two drugs administered together have the potential to metabolize differently in different individuals, as well as affect patients’ adherence to both drugs. A single compound that is able to provide both pain relief and diminished tolerance has the advantage of a defined ratio that we can optimize to ensure patients receive the maximum pain relief, while experiencing minimum adverse effects.”
Coop and his team conducted several in vitro and in vivostudies to determine the drug’s effectiveness in alleviating pain and diminishing tolerance over time. If future research and clinical trials are successful, UMB 425 could have a significant impact on the treatment and quality of life for individuals living with chronic pain.
“The clinical implication of this research has the potential to be tremendous,” says Mary Lynn McPherson, PharmD, BCPS, CPE, professor and vice chair for academic affairs in the Department of Pharmacy Practice and Science, and an international authority in the fields of pain management and palliative care. “If clinicians can prescribe lower doses of opioids, they will not have to raise a patient’s dose because of tolerance to the analgesic effects. Using lower doses will result in less severe adverse effects for the patient, both short-term effects such as nausea and constipation, as well as long-term adverse effects on the endocrine and immunologic systems. This would be a highly significant advance in pain management.”
The Latest on: Chronic Pain
- Ronald Melzack, Cartographer of Pain, Is Dead at 90on January 12, 2020 at 2:07 pm
Credit...McGill University Soldiers with deep wounds sometimes feel no pain at all for hours, while people without any detectable injury live in chronic physical anguish. How to explain that? Over ...
- Mysteries Of Chronic Pain; Julián Castro Drops Out Of 2020 Raceon January 10, 2020 at 10:44 am
Nearly 50 million people in the U.S. live with chronic pain, which is when a person's pain lasts longer than three months. National Geographic contributing writer Yudhijit Bhattacharjee joins us to ...
- New possible strategy for treating chronic pain due to burns may help sufferers including veteranson January 9, 2020 at 11:23 pm
New research shows how second-degree burns cause hard-to-treat chronic pain, and this understanding may be key to treating these complications, common in war veterans This research, published in ...
- Why do people develop chronic pain?on January 9, 2020 at 6:55 am
Mood disorders and the discovery of a pain signalling organ in the skin could explain why chronic pain occurs—and how to treat it. Burning, aching, stabbing, shooting, throbbing—there is no shortage ...
- Making Chronic Pain Optionalon January 8, 2020 at 7:04 pm
Imagine this—you are diagnosed with kidney stones. Your doctor explains that soon you will start passing the stones in your urine. How much pain do you think you will be in as you pass the stones?
- Lady Gaga Talks to Oprah About 'Psychotic Breaks,' Chronic Painon January 6, 2020 at 11:19 am
Gaga described the medical crisis as her brain flat lining -- an experience she said she'd never wish upon anyone. The singer told Oprah she's battling chronic pain, saying she was hurting at the ...
- Lady Gaga Opens Up About Her "Psychotic Break" and Chronic Pain with Oprahon January 6, 2020 at 9:09 am
On Saturday, 15,000 fans turned out in Ft. Lauderdale for Oprah Winfrey and WW's 2020 Vision: Your Life in Focus Tour. Lady Gaga made an appearance at the Florida event to discuss her personal ...
- Hemp Oil Can Help Relieve Chronic Painon January 6, 2020 at 5:42 am
/PRNewswire/ -- Hemp oil is extracted from the plant called "Cannabis Sativa". Despite the fact that it is a similar plant from which marijuana ...
- Lady Gaga Discusses Her "Psychotic Break" and Chronic Pain with Oprahon January 6, 2020 at 4:44 am
Lady Gaga and Oprah Winfrey during the WW & Oprah’s 2020 Vision: Your Life In Focus Tour on January 4, 2020. The singer also elaborated on how she deals with the chronic pain she experiences everyday.
- Pain Management: Yoga, arthritis and chronic painon January 5, 2020 at 11:43 pm
Physical activity is universally recommended as an essential part of arthritis and chronic pain management. Unfortunately, many people with arthritis and chronic pain tend to be sedentary or to limit ...
via Google News and Bing News